The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD ...
A large sensor, fast zoom lens, and tactile controls make this an appealing alternative to cameras like the Fujifilm X100 ...
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies to treat depression and post-traumatic stress disorder (PTSD), the latest ...
The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including major depression ...
WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the ...
Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on ...
U.S. Food and Drug Administration fast-tracks review of experimental depression and PTSD drugs, including psilocybin and methylone, through priority vouchers. What we know about security after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results